source
- Biotech sector logs 31 IPOs in 2026, with four more slated, still far below 2021 boomBiotech IPO activity has accelerated this year, with 31 companies completing public offerings so far, according to BioSpace data. This figure exceeds the totals from each of the previous four year…
- AbbVie reports Phase 3 success for lutikizumab in painful skin disease, eyes FDA filing next yearAbbVie announced positive Phase 3 trial results for its experimental IL-1α and IL-1β inhibitor lutikizumab, which is being developed to treat a debilitating skin condition. The study reported impr…